Skip to content
healthcare.dev

PHOSPHA 250 NEUTRAL

NDC 64980-729, Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate, tablet, from Rising Pharma Holdings, Inc..

Product NDC
64980-729
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-729 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM PHOSPHATE, DIBASIC, ANHYDROUS852 mg/1
  • POTASSIUM PHOSPHATE, MONOBASIC155 mg/1
  • SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE130 mg/1
Package NDCNDC-11Package
64980-729-0164980072901100 TABLET in 1 BOTTLE (64980-729-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9432adfc-6add-4ab4-ae93-2e2daf348be2
  • NADAC price for package 64980072901

    GET /v1/drugs/nadac/64980072901

Use it

Look up 64980-729 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-729 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-729. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.